RA Capital Nexus Fund III, L.P.

Director, Artiva Biotherapeutics, Inc.

Bought, 12 months

$75.4M

Sold, 12 months

$0.0M

Companies

Latest trade

Jul 24, 2026

Companies

Artiva Biotherapeutics, Inc.Director +$75.4M

Trades

ARTV Bought 41,319 shares at $9.99 $0.4M Jul 24

ARTV Bought 6,510,416 shares at $11.52 $75.0M May 11

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.